94 related articles for article (PubMed ID: 23025987)
1. Recipient PTPN22 -1123 C/C genotype predicts acute graft-versus-host disease after HLA fully matched unrelated bone marrow transplantation for hematologic malignancies.
Espinoza JL; Takami A; Onizuka M; Morishima Y; Fukuda T; Kodera Y; Akiyama H; Miyamura K; Mori T; Nakao S;
Biol Blood Marrow Transplant; 2013 Feb; 19(2):240-6. PubMed ID: 23025987
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
[TBL] [Abstract][Full Text] [Related]
3. The impact of the dose of natural killer cells in the graft on severe acute graft-versus-host disease after unrelated bone marrow transplantation.
Tanaka M; Kobayashi S; Numata A; Tachibana T; Takasaki H; Maruta A; Ishigatsubo Y; Kanamori H
Leuk Res; 2012 Jun; 36(6):699-703. PubMed ID: 22172462
[TBL] [Abstract][Full Text] [Related]
4. The recipient CXCL10 + 1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantation.
Nakata K; Takami A; Espinoza JL; Matsuo K; Morishima Y; Onizuka M; Fukuda T; Kodera Y; Akiyama H; Miyamura K; Mori T; Nakao S;
Clin Immunol; 2013 Feb; 146(2):104-11. PubMed ID: 23291247
[TBL] [Abstract][Full Text] [Related]
5. A single-nucleotide polymorphism of the Fcγ receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignancies.
Takami A; Espinoza JL; Onizuka M; Ishiyama K; Kawase T; Kanda Y; Sao H; Akiyama H; Miyamura K; Okamoto S; Inoue M; Ohtake S; Fukuda T; Morishima Y; Kodera Y; Nakao S;
Bone Marrow Transplant; 2011 Feb; 46(2):238-43. PubMed ID: 20400988
[TBL] [Abstract][Full Text] [Related]
6. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
7. The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation.
Horio T; Mizuno S; Uchino K; Mizutani M; Hanamura I; Espinoza JL; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Kodera Y; Doki N; Miyamura K; Mori T; Takami A
Transpl Immunol; 2017 Jun; 42():34-39. PubMed ID: 28487238
[TBL] [Abstract][Full Text] [Related]
8. High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation.
MacMillan ML; Radloff GA; Kiffmeyer WR; DeFor TE; Weisdorf DJ; Davies SM
Transplantation; 2003 Dec; 76(12):1758-62. PubMed ID: 14688528
[TBL] [Abstract][Full Text] [Related]
9. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
10. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials.
Chang YJ; Weng CL; Sun LX; Zhao YT
Ann Hematol; 2012 Mar; 91(3):427-37. PubMed ID: 21789620
[TBL] [Abstract][Full Text] [Related]
13. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
[TBL] [Abstract][Full Text] [Related]
14. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
15. Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation.
Yabe T; Matsuo K; Hirayasu K; Kashiwase K; Kawamura-Ishii S; Tanaka H; Ogawa A; Takanashi M; Satake M; Nakajima K; Tokunaga K; Inoko H; Saji H; Ogawa S; Juji T; Sasazuki T; Kodera Y; Morishima Y;
Biol Blood Marrow Transplant; 2008 Jan; 14(1):75-87. PubMed ID: 18158964
[TBL] [Abstract][Full Text] [Related]
16. Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation.
Kanda Y; Kanda J; Atsuta Y; Maeda Y; Ichinohe T; Ohashi K; Fukuda T; Miyamura K; Iida H; Mori T; Iwato K; Eto T; Kawa K; Morita S; Morishima Y
Br J Haematol; 2013 May; 161(4):566-77. PubMed ID: 23452319
[TBL] [Abstract][Full Text] [Related]
17. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.
Kasamon YL; Luznik L; Leffell MS; Kowalski J; Tsai HL; Bolaños-Meade J; Morris LE; Crilley PA; O'Donnell PV; Rossiter N; Huff CA; Brodsky RA; Matsui WH; Swinnen LJ; Borrello I; Powell JD; Ambinder RF; Jones RJ; Fuchs EJ
Biol Blood Marrow Transplant; 2010 Apr; 16(4):482-9. PubMed ID: 19925877
[TBL] [Abstract][Full Text] [Related]
18. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
[TBL] [Abstract][Full Text] [Related]
19. A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.
Nomoto H; Takami A; Espinoza JL; Matsuo K; Mizuno S; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Kodera Y; Doki N; Miyamura K; Mori T; Nakao S; Ohtake S; Morishita E
Int J Hematol; 2015 Oct; 102(4):460-70. PubMed ID: 26246110
[TBL] [Abstract][Full Text] [Related]
20. The role of adenotonsillectomy in graft-versus-host disease.
Schwab B; Raynor E
Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):57-60. PubMed ID: 22018926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
